BRIEF-UK's CMA Invites Comments On Blackrock/ Preqin Deal-March 2024-www.financetom.com

BRIEF-UK's CMA Invites Comments On Blackrock/ Preqin Deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-UK's CMA Invites Comments On Blackrock/ Preqin Deal

Dec 3, 2024 5:37 AM

Dec 3 (Reuters) - UK's CMA:

* COMPETITION AND MKTS - MERGER UPDATE: BLACKROCK ( BLK ) / PREQIN

EARLY ITC

* UK'S CMA SAYS INVITATION TO COMMENT IN BLACKROCK/PREQIN

DEAL

* CMA IS ISSUING THIS PRELIMINARY 'INVITATION TO COMMENT' TO

ALLOW

INTERESTED PARTIES TO SUBMIT TO CMA ANY INITIAL VIEWS ON IMPACT

THAT TRANSACTION COULD HAVE ON COMPETITION IN UK

* CMA HAS NOT YET LAUNCHED ITS FORMAL INVESTIGATION INTO

THIS

TRANSACTION.

* THIS INVITATION TO COMMENT IS FIRST PART OF CMA'S

INFORMATION-GATHERING PROCESS.

Source text:

Further company coverage:

Previous page： Why Symbotic Stock Is Trading Lower Tuesday Next page： Merck Lowers Earnings Guidance Despite Raising Revenue Midpoint; Shares Decline Intraday

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why Symbotic Stock Is Trading Lower Tuesday

Jul 30, 2024

Symbotic, Inc. ( SYM ) stock is trading lower Tuesday after the company reported worse-than-expected 2024 fiscal year third quarter earnings and issued fourth quarter guidance below estimates. What Happened: On Monday after the market closed, Symbotic ( SYM ) reported third quarter financial earnings, including a loss of two cents per share missing analyst estimates of a loss of...

Merck Lowers Earnings Guidance Despite Raising Revenue Midpoint; Shares Decline Intraday

Jul 30, 2024

01:17 PM EDT, 07/30/2024 (MT Newswires) -- Merck ( MRK ) lowered its 2024 earnings guidance to reflect the costs tied to its Eyebiotech acquisition despite slightly raising its revenue outlook midpoint, while posting stronger-than-expected second-quarter results. The drugmaker now expects full-year adjusted earnings per share in the $7.94 to $8.04 range, down from between $8.53 and $8.65 previously predicted....

US senator wants FAA to conduct thorough review into Boeing oversight

Jul 30, 2024

WASHINGTON, July 30 (Reuters) - The chair of the Senate Commerce Committee wants the Federal Aviation Administration to conduct a thorough review into its oversight of Boeing ( BA ) and other manufacturers, raising serious questions about the government's scrutiny of the planemaker. Senator Maria Cantwell in a letter seen by Reuters to FAA Administrator Mike Whitaker said the FAA...

L'Oreal 2Q sales rise but depressed China market weighs

Jul 30, 2024

PARIS, July 30 (Reuters) - French cosmetics giant L'Oreal reported a 5.3% rise in second-quarter sales, below expectations and likely further rattling investors already worried about the lack of rebound in the important Chinese market. The Paris-based company, which owns the Maybelline and Lancome brands, said on Tuesday that sales in the quarter reached 10.88 billion euros ($11.75 billion), up...